Schwannoma epidemiology and demographics
Schwannoma Microchapters |
Diagnosis |
---|
Treatment |
Case Studies |
Schwannoma epidemiology and demographics On the Web |
American Roentgen Ray Society Images of Schwannoma epidemiology and demographics |
Risk calculators and risk factors for Schwannoma epidemiology and demographics |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Maneesha Nandimandalam, M.B.B.S.[2]
Overview
Epidemiology and demographics
Incidence
- The incidence vestibular schwannoma is approximately 1 per 100,000 individuals.
- In [year], the incidence/prevalence of [disease name] was estimated to be [number range] cases per 100,000 individuals worldwide.
Prevalence
- The incidence/prevalence of [disease name] is approximately [number range] per 100,000 individuals worldwide.
- In [year], the incidence/prevalence of [disease name] was estimated to be [number range] cases per 100,000 individuals worldwide.
- The prevalence of [disease/malignancy] is estimated to be [number] cases annually
Age
- Patients of all age groups may develop vestibular schwannoma.
- The incidence is more common between the 3rd and 5th decades of life.
- The median age at diagnosis is 5th decade.[1]
Race
- The incidence seems to be higher in Asian population and lower in Hispanics and African-Americans.[2]
Gender
- Vestibular schwannoma affects men and women equally with a slight predilection towards female population. [3]
Region
- The majority of [disease name] cases are reported in [geographical region].
- [Disease name] is a common/rare disease that tends to affect [patient population 1] and [patient population 2].
Developed Countries
Developing Countries
References
- ↑ Propp JM, McCarthy BJ, Davis FG, Preston-Martin S (January 2006). "Descriptive epidemiology of vestibular schwannomas". Neuro-oncology. 8 (1): 1–11. doi:10.1215/S1522851704001097. PMC 1871924. PMID 16443943.
- ↑ Koo M, Lai JT, Yang EY, Liu TC, Hwang JH (October 2018). "Incidence of Vestibular Schwannoma in Taiwan from 2001 to 2012: A Population-Based National Health Insurance Study". Ann. Otol. Rhinol. Laryngol. 127 (10): 694–697. doi:10.1177/0003489418788385. PMID 30032646.
- ↑ Brown CM, Ahmad ZK, Ryan AF, Doherty JK (January 2011). "Estrogen receptor expression in sporadic vestibular schwannomas". Otol. Neurotol. 32 (1): 158–62. doi:10.1097/MAO.0b013e3181feb92a. PMC 3073320. PMID 21099731.